A commentary on ‘The role of cytoreductive nephrectomy in metastatic renal cell carcinoma in the targeted therapy and immunological therapy era: a systematic review and meta-analysis’
Year: 2024
Type: review
Abstract: aDepartment of Nephrology,The Second People's Hospital of Jiangyou,Jiangyou,621700,Sichuan,China bSchool of Medical Technology,Xi 'an Medical College,Xi 'an, 710021,Shanxi,China cDepartment of Nephrology,Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,Shaanxi,China dDepartment of Neurosurgery,Second Hospital of the Air Force Medical University (Tangdu Hospital), Xi 'an, 710038,Shaanxi,China Co-authors: Liyao Chen and Yiqiang Liu equally contributed to the article. Sponsorships or competing interests that may be relevant to content are disclosed at the end of this article Published online ■ ■ *Corresponding author. Address: Department of Nephrology,Affiliated Hospital of Shaanxi University of Chinese Medicine,Xianyang 712000,Shaanxi,China. E-mail address: [email protected] (G. Zhou). This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0/
Source: International Journal of Surgery
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Estimated APC paid: $3,450
OpenAlex ID: W4392751089
